Atai Life Sciences Return on Investment 2020-2024 | ATAI
Atai Life Sciences ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2024-03-31 | $-0.12B | $0.24B | -45.70% |
2023-12-31 | $-0.13B | $0.26B | -48.60% |
2023-09-30 | $-0.13B | $0.29B | -49.29% |
2023-06-30 | $-0.14B | $0.23B | -52.17% |
2023-03-31 | $-0.14B | $0.26B | -49.23% |
2022-12-31 | $-0.14B | $0.28B | -45.35% |
2022-09-30 | $-0.15B | $0.31B | -43.90% |
2022-06-30 | $-0.15B | $0.32B | -38.19% |
2022-03-31 | $-0.17B | $0.36B | -40.61% |
2021-12-31 | $-0.14B | $0.39B | -37.01% |
2021-09-30 | $-0.18B | $0.46B | -60.51% |
2021-06-30 | $-0.15B | $0.49B | -85.55% |
2021-03-31 | $-0.10B | $0.12B | -174.55% |
2020-12-31 | $-0.10B | $0.10B | -424.49% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.223B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $16.800B | 0.00 |
Quest Diagnostics (DGX) | United States | $15.206B | 15.72 |
DaVita (DVA) | United States | $12.153B | 15.10 |
Encompass Health (EHC) | United States | $8.638B | 22.11 |
Chemed (CHE) | United States | $8.214B | 25.46 |
Elanco Animal Health (ELAN) | United States | $7.131B | 18.50 |
Option Care Health (OPCH) | United States | $4.815B | 18.22 |
RadNet (RDNT) | United States | $4.353B | 90.65 |
Amedisys (AMED) | United States | $3.000B | 21.25 |
Astrana Health (ASTH) | United States | $2.272B | 30.73 |
Addus HomeCare (ADUS) | United States | $1.901B | 27.19 |
LifeStance Health (LFST) | United States | $1.877B | 0.00 |
U.S Physical Therapy (USPH) | United States | $1.393B | 37.27 |
Pennant (PNTG) | United States | $0.697B | 36.81 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.531B | 0.00 |
Daxor (DXR) | United States | $0.045B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.014B | 0.00 |
Psychemedics (PMD) | United States | $0.014B | 0.00 |
Ontrak (OTRK) | United States | $0.010B | 0.00 |
IMAC Holdings (BACK) | United States | $0.002B | 0.00 |